YEATS4 is also associated with tumor size, depth, distant metastasis, and poor prognosis (Kiuchi et al., 2018), suggesting that YEATS4 could be a target for developing oncological drugs and improving the prognosis of gastric cancer. This evidence concerns the gene YEATS4 and neoplasm.